More about

Lymphoma

News
May 24, 2024
2 min read
Save

No cardiac effects from topical hypericin in patients with mycosis fungoides

No cardiac effects from topical hypericin in patients with mycosis fungoides

Topical hypericin showed efficacy in treating mycosis fungoides without significant skin absorption or significant cardiac changes, according to a study.

News
May 15, 2024
1 min read
Save

FDA approves Breyanzi CAR-T for follicular lymphoma

FDA approves Breyanzi CAR-T for follicular lymphoma

The FDA granted accelerated approval to lisocabtagene maraleucel for treatment of adults with relapsed or refractory follicular lymphoma who received at least two prior lines of systemic therapy.

News
May 03, 2024
1 min read
Save

Calquence delays disease progression as first-line treatment for mantle cell lymphoma

Calquence delays disease progression as first-line treatment for mantle cell lymphoma

The addition of acalabrutinib to standard-of-care chemoimmunotherapy significantly extended PFS compared with standard therapy alone in a randomized study, according to press release the agent’s manufacturer.

News
April 19, 2024
4 min read
Save

Blood tests may predict which patients with lymphoma will have poor outcomes after CAR-T

Blood tests may predict which patients with lymphoma will have poor outcomes after CAR-T

Two blood biomarkers — pre-lymphodepletion C-reactive protein and ferritin — may help predict which patients with lymphoma are at risk for poor outcomes after chimeric antigen receptor T-cell therapy.

News
April 18, 2024
1 min read
Save

Dupilumab treatment for atopic dermatitis linked to cutaneous T-cell lymphoma development

Dupilumab treatment for atopic dermatitis linked to cutaneous T-cell lymphoma development

A new study finds that dupilumab is associated with an increased risk for cutaneous T-cell lymphoma in patients taking the drug for atopic dermatitis.

News
April 16, 2024
1 min read
Save

Regimen improves OS in diffuse large B-cell lymphoma

Regimen improves OS in diffuse large B-cell lymphoma

The addition of glofitamab-gxbm to gemcitabine and oxaliplatin improved OS among patients with relapsed or refractory diffuse large B-cell lymphoma compared with rituximab, gemcitabine and oxaliplatin, according to the agent’s manufacturer.

News
April 08, 2024
3 min read
Save

Enalapril does not prevent chemotherapy-related heart damage in breast cancer, lymphoma

Enalapril does not prevent chemotherapy-related heart damage in breast cancer, lymphoma

ATLANTA — Enalapril plus standard care was not superior to standard care alone for preventing cardiotoxicity in patients receiving treatment for breast cancer or lymphoma, according to new data from the PROACT trial.

News
March 27, 2024
4 min read
Save

‘We were shocked’: CAR-T rapidly reduces size of brain tumors in phase 1 trial

‘We were shocked’: CAR-T rapidly reduces size of brain tumors in phase 1 trial

A novel bivalent-targeting, intrathecally delivered chimeric antigen receptor T-cell therapy decreased tumor size in patients with recurrent glioblastoma, according to results from a phase 1 study published in Nature Medicine.

News
March 13, 2024
4 min read
Save

Risk factors identified for secondary leukemia in patients who received CAR T cells

Risk factors identified for secondary leukemia in patients who received CAR T cells

Researchers at Mayo Clinic have identified clinical factors associated with increased risk for developing myeloid neoplasms following chimeric antigen receptor T-cell therapy, according to data published in JAMA Oncology.

News
March 08, 2024
1 min read
Save

FDA grants accelerated approval to Brukinsa for advanced follicular lymphoma

FDA grants accelerated approval to Brukinsa for advanced follicular lymphoma

The FDA granted accelerated approval to zanubrutinib in combination with obinutuzumab for adults with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy, according to a press release.

View more